University of Cambridge is offering a four-year PhD studentship based in Cambridge Institute of Medical Research (CIMR) and the AstraZeneca Discovery Centre. The student will undertake a collaborative project co-supervised by CIMR and AstraZeneca investigators, with opportunities to work across both sites.
The project focuses on delivering senomodulatory nanoparticles to AT2 cells to address idiopathic pulmonary fibrosis, utilizing human alveolar organoids and automated screening platforms in
#J-18808-Ljbffr
PhD: Targeted Nanoparticle Therapy for Senescent Lung Cells in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
